Gastroenteritis: Clinical Trials

5,720 trials for Gastroenteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2786 completed, 972 unknown, 690 recruiting, 517 terminated. 1491 Not applicable, 970 Phase 2, 677 Phase 3, 490 Phase 1, 408 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1491Completed 650, Unknown 316, Recruiting 194, Terminated 117, Not yet recruiting 90, Active not recruiting 50, Withdrawn 50, Enrolling by invitation 17, Suspended 7
Phase 2970Completed 480, Terminated 169, Recruiting 114, Unknown 89, Withdrawn 48, Active not recruiting 42, Not yet recruiting 20, Enrolling by invitation 5, Suspended 3
Phase 3677Completed 389, Terminated 101, Unknown 73, Recruiting 51, Active not recruiting 34, Withdrawn 19, Not yet recruiting 7, Enrolling by invitation 2, Suspended 1
Phase 1490Completed 276, Terminated 57, Unknown 48, Recruiting 45, Withdrawn 27, Not yet recruiting 23, Active not recruiting 10, Enrolling by invitation 3, Suspended 1
Phase 4408Completed 206, Unknown 62, Recruiting 44, Terminated 43, Not yet recruiting 22, Withdrawn 18, Active not recruiting 10, Enrolling by invitation 3
Early Phase 165Unknown 22, Completed 16, Recruiting 8, Not yet recruiting 7, Withdrawn 5, Terminated 3, Active not recruiting 2, Enrolling by invitation 2

Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Digital Mind Body Intervention mobile application - Crohn's Disease, Ulcerative Colitis
Not applicableNot yet recruitingMontefiore Medical Center402027-07-012026-11-16
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic
Phase 3Not yet recruitingMcMaster Children's Hospital1802027-04-012026-10-09
ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery
5-ASA, Placebo - Ulcerative Colitis (UC), Pouchitis
Phase 4Not yet recruitingUniversity Hospital, Linkoeping1102027-04-012026-08-19
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized Study
Irrigation with PVI, Usual care - Acute, Perforated Appendicitis
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston17502027-03-012025-02-10
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
Xylitol - Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection
Early Phase 1Not yet recruitingBrigham and Women's Hospital692027-03-012026-11-16
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Phase 1Not yet recruitingBrigham and Women's Hospital992027-03-012026-11-18
Duodenal Mucosa Responses to Endoscopic Food Challenges in Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome With Self-reported Food Intolerances: A Feasibility Study
Upper diagnostic endoscopy with food challenges and biopsies - Food Intolerance, IBD (Inflammatory Bowel Disease)
Not applicableNot yet recruitingMcMaster University122027-02-012026-11-19
Oral N-acetylglucosamine in Crohn's Disease
N-Acetylglucosamine (GlcNAc) - Crohns Disease
Phase 2Not yet recruitingJohns Hopkins University402027-01-052026-11-05
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Tirzepatide, Loperamide, Diphenoxylate/Atropine - Pouch, Ileal, Pouches, Ileoanal
Phase 4RecruitingUniversity of North Carolina, Chapel Hill202027-01-042026-11-18
Perforated Appendicitis and Postoperative Antibiotics Pilot Trial
Postoperative antibiotico-prophylaxis, No postoperative antibiotics - Perforated Appendicitis
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1002027-01-012026-09-17
Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD)
Not yet recruitingBrigham and Women's Hospital1002027-01-012026-10-20
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis
Early Phase 1Not yet recruitingJinling Hospital, China122027-01-012026-10-22
Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis
treatment withdrawal - Ulcerative Colitis in Remission
Phase 4Not yet recruitingAssistance Publique Hopitaux De Marseille2242027-01-012026-11-10

Showing 20 of 5720. Sign in to see all of them.

Narrower conditions

Crohn Disease (1954)  ·  Colitis, Ulcerative (1802)  ·  Inflammatory Bowel Diseases (1556)  ·  Appendicitis (403)  ·  Eosinophilic Esophagitis (234)  ·  Enterocolitis, Necrotizing (224)  ·  Mucositis (208)  ·  Colitis (127)  ·  Diverticulitis (100)  ·  Diarrhea (96)  ·  Gastritis (92)  ·  Esophagitis (88)  ·  Colorectal Neoplasms (87)  ·  Arthritis, Rheumatoid (86)

Broader conditions

Digestive System Diseases (5669)  ·  Gastrointestinal Diseases (5638)  ·  Intestinal Diseases (4855)  ·  Inflammatory Bowel Diseases (2273)  ·  Colonic Diseases (2057)  ·  Colitis (1779)  ·  Pathological Conditions, Signs and Symptoms (890)  ·  Infections (730)  ·  Pathologic Processes (451)  ·  Immune System Diseases (450)  ·  Cecal Diseases (403)  ·  Intraabdominal Infections (399)  ·  Esophageal Diseases (378)  ·  Signs and Symptoms (374)

Interventions

Infliximab (147)  ·  Mesalamine (117)  ·  Adalimumab (109)  ·  vedolizumab (100)  ·  Fecal Microbiota Transplantation (85)  ·  Ustekinumab (66)  ·  Metronidazole (54)  ·  Appendectomy (49)  ·  Azathioprine (47)  ·  Blood Specimen Collection (47)  ·  Budesonide (43)  ·  Colonoscopy (39)  ·  Certolizumab Pegol (35)  ·  Probiotics (35)  ·  Endoscopy (33)

Sponsors

Takeda (96)  ·  AbbVie (74)  ·  Assiut University (69)  ·  Mayo Clinic (65)  ·  Pfizer (60)  ·  GlaxoSmithKline (57)  ·  Janssen Research & Development, LLC (46)  ·  Assistance Publique - Hôpitaux de Paris (41)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (41)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (35)  ·  AstraZeneca (34)  ·  Children's Hospital Medical Center, Cincinnati (34)  ·  Central Hospital, Nancy, France (30)  ·  Ferring Pharmaceuticals (30)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (30)

Countries

United States (1802)  ·  Canada (613)  ·  France (604)  ·  China (510)  ·  United Kingdom (498)  ·  Italy (485)  ·  Germany (475)  ·  Israel (392)  ·  Belgium (391)  ·  Poland (386)  ·  Spain (370)  ·  Netherlands (363)  ·  South Korea (292)  ·  Hungary (276)  ·  Australia (273)

Top investigators

Arie Levine, MD (10)

Results publications

PMID 40243391, PMID 40357993, PMID 40013523, PMID 29380251, PMID 32445184, PMID 26893500, PMID 35648151, PMID 36124702, PMID 37368103, PMID 29850873, PMID 30476584, PMID 30739254, PMID 31077827, PMID 31599001, PMID 32816215, PMID 33684552, PMID 35792493, PMID 36342120, PMID 36526796, PMID 36931693, PMID 38425446, PMID 39778975, PMID 19735233, PMID 20195905, PMID 25996351, PMID 32635680, PMID 32766762, PMID 32870265, PMID 32964215, PMID 33127596, PMID 33324993, PMID 33513294, PMID 34614208, PMID 35380664, PMID 35380740, PMID 36150926, PMID 36208720, PMID 36336750, PMID 37224198, PMID 37402275, PMID 37560161, PMID 38096402, PMID 38310565, PMID 38778549, PMID 41264726, PMID 41763462, PMID 42248437, PMID 16339095, PMID 19596014, PMID 21129076

NIH funding

2023 (53), 2017 (44), 2016 (32), 2014 (30), 2025 (29), 2018 (28), 2015 (26), 2019 (25), 2009 (14), 2008 (11), 2004 (6), 2005 (4), U54AI117804 (4), UL1TR001082 (4), U10HD021364 (3)